Elisabeth Wieduwild
Scientist ImCheck Therapeutics
Elisabeth Wieduwild, PhD, is a scientist at ImCheck Therapeutics, where she contributes to advancing immunotherapeutic strategies. With a strong academic foundation from her PhD at the Centre d’Immunologie de Marseille-Luminy (CIML) and a joint postdoctoral fellowship at CIML and the LAI in Marseille, Elisabeth brings deep expertise in immunology and translational research. Her transition to industry has expanded her impact as both a scientist and a project leader.
Seminars
Thursday 4th December 2025
Characterising & Optimising Humanised Mouse Models to Empower Gamma-Delta Therapy Development
4:00 pm
- Addressing the limitations of traditional mouse models for gamma-delta T cell studies and strategies for identifying or developing humanised mouse models
- Optimising experimental variables—such as cell source, transfer method, and tumour type—to align with specific therapeutic objectives, from efficacy assessment to immune profiling
- Implementing robust, foundational assays to evaluate gamma-delta T cell presence and activity following therapeutics, ensuring reliable data generation and efficient model characterisation
